Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature
The Journal of Clinical Endocrinology & Metabolism · 22.04.2025 · 110 (5) · e1573-e1579
DOI: 10.1210/clinem/dgae523 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 26.07.2024. Verfasst von Marta Araujo-Castro und 15 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain. Hauptthemen laut MEDLINE: Genetic Testing, Hyperaldosteronism. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Context
It is estimated that about 5% of the primary aldosteronism (PA) cases are of hereditary origin (familial hyperaldosteronism, FH). To date, 4 forms of FH have been reported. However, in general little is known about the genetic causes that lead to the development of PA.
Objective
This work aimed to determine the rate of genetic testing for FH in the SPAIN-ALDO Registry and to describe the clinical characteristics of patients with FH. In addition, a literature review of reports of FH cases was performed.
Methods
A retrospective multicenter study of PA in patients followed in 35 Spanish tertiary hospitals (SPAIN-ALDO Registry).
Results
Twenty-five of the 855 patients (3%) with PA included in the registry underwent genetic testing for FH, with complete results available for only 24 patients. However, we found that there were 57 patients who met the criteria for performing a genetic study of PA. Only 8 out of these 57 patients were genetically tested (14.0%), while the reasons to perform a genetic study in the remaining 17 genetically studied cases were quite heterogeneous. A positive result for FH was found in only one case for FH type III (KCNJ5 pathogenic variant). A systematic review of the literature was performed and identified a total of 25 articles reporting 246 patients with FH type I, 12 articles reporting 72 patients with FH type II, 14 articles reporting 29 cases of FH type III, and 3 articles reporting 12 patients with FH type IV.
Conclusion
The genetic study of FH is often scarce in real-world clinical practice, as 86% of patients with criteria to undergo genetic study were not evaluated in our cohort. Nevertheless, FH is an uncommon cause of PA, representing only 0.2% of cases in the SPAIN-ALDO Registry, although its prevalence may be as high as 4% among suspected cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrinology & Nutrition Department, Hospital Universitario Ramón y Cajal, 28034 Madrid, Spain.
- Instituto de Investigación Biomédica Ramón y Cajal (IRYCIS), 28034 Madrid, Spain.
- Endocrinology & Nutrition Department, Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS FJD, UAM), Hospital Universitario Fundación Jiménez Díaz, 28040 Madrid, Spain.
- Endocrinology & Nutrition Department, Hospital Universitario de Albacete, 02006 Albacete, Spain.
- Endocrinology & Nutrition Department, Hospital Universitario La Paz, 28046 Madrid, Spain.
- Endocrinology & Nutrition Department, Hospital Universitario de Basurto, 48013 Bilbao, Spain.
ORCID-Profile: Marta Araujo-Castro, Jorge Gabriel Ruiz-Sánchez, Cristina Lamas, M Gonzalez-Boillos, Paolo Mulatero
Zitieren
APA
Araujo-Castro, M., Ruiz-Sánchez, J. G., Gonzalvo, C., Lamas, C., Parra Ramírez, P., Martín Marcos-Rojas, P., Paja, M., Robles Lázaro, C., Michalopoulou, T., Tous, M., Gonzalez-Boillos, M., Recio-Córdova, J. M., Casteras, A., Fernández-Álvarez, P., Barca Tierno, V., & Mulatero, P. (2025). Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature. The Journal of Clinical Endocrinology & Metabolism, 110(5), e1573-e1579. https://doi.org/10.1210/clinem/dgae523
Vancouver
Araujo-Castro M, Ruiz-Sánchez JG, Gonzalvo C, Lamas C, Parra Ramírez P, Martín Marcos-Rojas P, et al. Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature. The Journal of Clinical Endocrinology & Metabolism. 2025;110(5):e1573-e1579. doi:10.1210/clinem/dgae523
BibTeX
@article{AraujoCastro2025,
author = {Araujo-Castro, Marta and Ruiz-Sánchez, Jorge Gabriel and Gonzalvo, César and Lamas, Cristina and Parra Ramírez, Paola and Martín Marcos-Rojas, Patricia and Paja, Miguel and Robles Lázaro, Cristina and Michalopoulou, Theodora and Tous, María and Gonzalez-Boillos, M and Recio-Córdova, José María and Casteras, Anna and Fernández-Álvarez, Paula and Barca Tierno, Verónica and Mulatero, Paolo},
title = {Genetic Testing for Primary Aldosteronism in SPAIN: Results From the SPAIN-ALDO Registry and Review of the Literature},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {5},
pages = {e1573--e1579},
doi = {10.1210/clinem/dgae523}
}
EUVIMED